UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease

The Journal of neuroscience, 2002-10, Vol.22 (20), p.9099-9103

2002

Volltextzugriff (PDF)

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease

Movement disorders, 2005-08, Vol.20 (8), p.932-936

2005

Volltextzugriff (PDF)

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease

Neurotherapeutics, 2017-04, Vol.14 (2), p.405-416

2017

Volltextzugriff (PDF)

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary Clinical Validity

Journal of clinical and experimental neuropsychology, 1998-06, Vol.20 (3), p.310-319

1998

Volltextzugriff (PDF)

Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates

Experimental neurology, 2005-03, Vol.192 (1), p.73-78

2005

Volltextzugriff (PDF)

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

Neurology, 2001-11, Vol.57 (10), p.1829-1834

2001

Volltextzugriff (PDF)

Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity

Neurobiology of disease, 2005-11, Vol.20 (2), p.562-573

2005

Volltextzugriff (PDF)

Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats

Journal of neuroscience research, 2003-06, Vol.72 (6), p.768-780

2003

Volltextzugriff (PDF)

A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model

Pharmacology, biochemistry and behavior, 2008-10, Vol.90 (4), p.540-544

2008

Volltextzugriff (PDF)

Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study

Movement disorders, 2001-05, Vol.16 (3), p.515-520

2001

Volltextzugriff (PDF)

Quetiapine Attenuates Levodopa-Induced Motor Complications in Rodent and Primate Parkinsonian Models

Experimental neurology, 2002-10, Vol.177 (2), p.557-564

2002

Volltextzugriff (PDF)

Glutamate release inhibition ineffective in Levodopa-induced motor complications

Movement disorders, 2006-09, Vol.21 (9), p.1380-1383

2006

Volltextzugriff (PDF)

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration

Brain research, 1998-11, Vol.813 (1), p.150-159

1998

Volltextzugriff (PDF)

Distinct Pathological Features of the Gallyas- and Tau-positive Glia in the Parkinsonism-Dementia Complex and Amyotrophic Lateral Sclerosis of Guam

Journal of neuropathology and experimental neurology, 1997-03, Vol.56 (3), p.308-316

1997

Volltextzugriff (PDF)

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

Brain research, 1994-10, Vol.662 (1), p.69-74

1994

Volltextzugriff (PDF)

Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal nmda receptor subunits

Brain research, 1999-03, Vol.821 (2), p.433-442

1999

Volltextzugriff (PDF)

Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease

Movement disorders, 2004-10, Vol.19 (10), p.1183-1186

2004

Volltextzugriff (PDF)

Continuous transdermal dopaminergic stimulation in advanced Parkinson's Disease

Clinical neuropharmacology, 2001-05, Vol.24 (3), p.163-169

2001

Volltextzugriff (PDF)

Neuroprotective effects of prostaglandin A1 in animal models of focal ischemia

Brain research, 2005-03, Vol.1039 (1-2), p.203-206

2005

Volltextzugriff (PDF)

NMDA receptor blockade reverses motor response alterations induced by levodopa

Neuroreport, 1994-12, Vol.5 (18), p.2586-2588

1994

Volltextzugriff (PDF)

Mapping of Rat Brain Using the Synuclein-1 Monoclonal Antibody Reveals Somatodendritic Expression of α-Synuclein in Populations of Neurons Homologous to those Vulnerable to Lewy Body Formation in Human Synucleopathies

Journal of neuropathology and experimental neurology, 2003-10, Vol.62 (10), p.1060-1075

2003

Volltextzugriff (PDF)

A trial of dextromethorphan in parkinsonian patients with motor response complications

Movement disorders, 1998-05, Vol.13 (3), p.414-417

1998

Volltextzugriff (PDF)

Autoradiographic distribution of substance P receptors in rat central nervous system

Nature (London), 1983-06, Vol.303 (5919), p.714-716

1983

Volltextzugriff (PDF)

Gene transfer of constitutively active protein kinase C into striatal neurons accelerates onset of levodopa-induced motor response alterations in parkinsonian rats

Brain research, 2003-05, Vol.971 (1), p.18-30

2003

Volltextzugriff (PDF)

Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat

Neuroscience letters, 1997-05, Vol.228 (1), p.5-8

1997

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(135)

Publikationsform

Artikel
(188)

Sprache

Englisch
(188)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary Clinical Validity

Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity

Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats

A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model

Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study

Quetiapine Attenuates Levodopa-Induced Motor Complications in Rodent and Primate Parkinsonian Models

Glutamate release inhibition ineffective in Levodopa-induced motor complications

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration

Distinct Pathological Features of the Gallyas- and Tau-positive Glia in the Parkinsonism-Dementia Complex and Amyotrophic Lateral Sclerosis of Guam

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal nmda receptor subunits

Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease

Continuous transdermal dopaminergic stimulation in advanced Parkinson's Disease

Neuroprotective effects of prostaglandin A1 in animal models of focal ischemia

NMDA receptor blockade reverses motor response alterations induced by levodopa

Mapping of Rat Brain Using the Synuclein-1 Monoclonal Antibody Reveals Somatodendritic Expression of α-Synuclein in Populations of Neurons Homologous to those Vulnerable to Lewy Body Formation in Human Synucleopathies

A trial of dextromethorphan in parkinsonian patients with motor response complications

Autoradiographic distribution of substance P receptors in rat central nervous system

Gene transfer of constitutively active protein kinase C into striatal neurons accelerates onset of levodopa-induced motor response alterations in parkinsonian rats

Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat

Aktive Filter

Suchergebnisse filtern